| Primary |
| Multiple Sclerosis |
45.9% |
| Relapsing-remitting Multiple Sclerosis |
11.6% |
| Drug Use For Unknown Indication |
9.3% |
| Depression |
4.8% |
| Hypertension |
4.7% |
| Insomnia |
2.6% |
| Secondary Progressive Multiple Sclerosis |
2.4% |
| Prophylaxis |
2.3% |
| Product Used For Unknown Indication |
2.0% |
| Headache |
1.8% |
| Anxiety |
1.8% |
| Pain |
1.8% |
| Contraception |
1.3% |
| Premedication |
1.3% |
| Multiple Sclerosis Relapse |
1.3% |
| Muscle Spasms |
1.1% |
| Diabetes Mellitus |
1.1% |
| Sleep Disorder Therapy |
1.0% |
| Constipation |
0.9% |
| Antidepressant Therapy |
0.8% |
|
| Vomiting |
11.0% |
| Multiple Sclerosis Relapse |
10.7% |
| Pyrexia |
10.2% |
| Multiple Sclerosis |
7.2% |
| Weight Decreased |
6.0% |
| Urinary Tract Infection |
5.8% |
| Visual Impairment |
5.5% |
| Syncope |
4.7% |
| Tremor |
4.5% |
| Muscular Weakness |
4.2% |
| Urinary Incontinence |
3.8% |
| Skin Necrosis |
3.3% |
| Death |
3.2% |
| Visual Acuity Reduced |
3.2% |
| Liver Function Test Abnormal |
3.0% |
| Hepatic Steatosis |
2.8% |
| Mobility Decreased |
2.8% |
| Pain In Extremity |
2.8% |
| Skin Reaction |
2.7% |
| Weight Increased |
2.7% |
|
| Secondary |
| Multiple Sclerosis |
26.7% |
| Relapsing-remitting Multiple Sclerosis |
14.7% |
| Depression |
7.1% |
| Insomnia |
6.2% |
| Prophylaxis |
5.0% |
| Anxiety |
5.0% |
| Hypertension |
4.2% |
| Headache |
3.6% |
| Contraception |
3.5% |
| Drug Use For Unknown Indication |
2.7% |
| Pain |
2.5% |
| Fatigue |
2.5% |
| Vitamin Supplementation |
2.5% |
| Multiple Sclerosis Relapse |
2.3% |
| Secondary Progressive Multiple Sclerosis |
2.2% |
| Constipation |
2.1% |
| Sinusitis |
2.0% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.9% |
| Premedication |
1.6% |
| Asthma |
1.6% |
|
| Vomiting |
12.5% |
| Weight Decreased |
11.3% |
| Vaginal Haemorrhage |
8.3% |
| Pyrexia |
7.5% |
| Visual Impairment |
6.7% |
| Weight Increased |
6.3% |
| Multiple Sclerosis |
4.2% |
| Pain |
4.2% |
| Status Asthmaticus |
4.2% |
| Syncope |
4.2% |
| Viral Infection |
3.8% |
| White Blood Cell Count Increased |
3.8% |
| Pulmonary Oedema |
3.3% |
| Scar |
3.3% |
| Appendicitis |
2.9% |
| Palpitations |
2.9% |
| Tremor |
2.9% |
| Urinary Retention |
2.9% |
| Anaemia |
2.5% |
| Paraplegia |
2.5% |
|
| Concomitant |
| Multiple Sclerosis |
50.0% |
| Relapsing-remitting Multiple Sclerosis |
10.0% |
| Facial Neuralgia |
5.3% |
| Drug Use For Unknown Indication |
4.1% |
| Product Used For Unknown Indication |
4.1% |
| Chronic Lymphocytic Leukaemia |
2.9% |
| Pain |
2.4% |
| Bladder Disorder |
1.8% |
| Blood Cholesterol |
1.8% |
| Blood Pressure |
1.8% |
| Breast Neoplasm |
1.8% |
| Depression |
1.8% |
| Dyspepsia |
1.8% |
| Hypertension |
1.8% |
| Hypothyroidism |
1.8% |
| Muscle Spasms |
1.8% |
| Thyroid Disorder |
1.8% |
| Antidepressant Therapy |
1.2% |
| Constipation |
1.2% |
| Insomnia |
1.2% |
|
| Death |
6.7% |
| Drug Ineffective |
6.7% |
| Pyrexia |
6.7% |
| Suicidal Ideation |
6.7% |
| Varicella |
6.7% |
| Basal Cell Carcinoma |
4.4% |
| Electrocardiogram Qt Prolonged |
4.4% |
| Epilepsy |
4.4% |
| Invasive Ductal Breast Carcinoma |
4.4% |
| Ischaemic Stroke |
4.4% |
| Jaundice |
4.4% |
| Joint Swelling |
4.4% |
| Lymphopenia |
4.4% |
| Multiple Sclerosis Relapse |
4.4% |
| Oesophageal Candidiasis |
4.4% |
| Progressive Multifocal Leukoencephalopathy |
4.4% |
| Quadriparesis |
4.4% |
| Rash Maculo-papular |
4.4% |
| Red Blood Cell Count Decreased |
4.4% |
| Somnolence |
4.4% |
|
| Interacting |
| Multiple Sclerosis |
53.1% |
| Blood Cholesterol Increased |
12.5% |
| Blood Pressure Abnormal |
12.5% |
| Muscle Spasms |
12.5% |
| Diabetes Mellitus |
9.4% |
|
| Thrombosis |
57.1% |
| Jaundice |
42.9% |
|
